HCM
XENT

Highbridge Capital Management’s Intersect ENT, Inc XENT Stock Holding History

Highbridge Capital Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-16,481
Closed -$534K – 1858
2017
Q4 		$534K Buy
+16,481
New +$494K 0.01% 858

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Highbridge Capital Management's XENT Position: Q1 2018 in Review

Highbridge Capital Management sold out of Intersect ENT, Inc (XENT) in Q1 2018, closing a stake of 16,481 shares — an estimated $534K sold.

Highbridge Capital Management first reported a position in XENT in Q4 2017 and held it in 1 quarter. The position peaked at $534K in Q4 2017. 172 funds tracked by Wall St. Rank hold XENT as of Q1 2018.

  • Highbridge Capital Management reported no remaining Intersect ENT, Inc position as of Q1 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 16,481 Intersect ENT, Inc shares in Q1 2018, an estimated $534K.
  • Highbridge Capital Management first reported a position in Intersect ENT, Inc in Q4 2017 and held it in 1 quarter.
  • Highbridge Capital Management's Intersect ENT, Inc position peaked at $534K in Q4 2017.
  • 172 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2018.

Based on Highbridge Capital Management's 13F filing for Q1 2018, filed 15 May 2018.